Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 02 Nov 2021

Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer in China

in Drugs Outcomes Research and Policies

Liu Qiao
Zhen Zhou
Xiaohui Zeng
Chongqing Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.728440

5,394 views
43 citations

Review

Published on 01 Nov 2021

Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation

in Drugs Outcomes Research and Policies

Lilia Bardoscia
Nadia Pasinetti
Luca Triggiani
Salvatore Cozzi
Angela Sardaro

Frontiers in Pharmacology

doi 10.3389/fphar.2021.746853

4,136 views
19 citations

Review

Published on 01 Nov 2021

Drug-Repositioning Approaches Based on Medical and Life Science Databases

in Drugs Outcomes Research and Policies

Yoshito Zamami
Hirofumi Hamano
Takahiro Niimura
Fuka Aizawa
Kenta Yagi
Mitsuhiro Goda
Yuki Izawa-Ishizawa
Keisuke Ishizawa

Frontiers in Pharmacology

doi 10.3389/fphar.2021.752174

8,056 views
14 citations

Systematic Review

Published on 01 Nov 2021

HIV Protease Inhibitors and Insulin Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in Drugs Outcomes Research and Policies

Violet Dismas Kajogoo
Mary Gorret Atim
Demeke Amare
Melka Geleta
Yilkal Muchie
Hanna Amanuel Tesfahunei
Willyhelmina Olomi
Joan Acam
Tsegahun Manyazewal

Frontiers in Pharmacology

doi 10.3389/fphar.2021.635089

4,600 views
14 citations

Original Research

Published on 29 Oct 2021

Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte–Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study

in Drugs Outcomes Research and Policies

Qiuji Wu
Qiu Li
Jun Zhang
Zhumei Luo
Jin Zhou
Jing Chen
Yong Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.690874

3,264 views
2 citations

Systematic Review

Published on 29 Oct 2021

Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials

in Drugs Outcomes Research and Policies

Siliang Man
Lidong Hu
Xiaojian Ji
Yiwen Wang
Yingpei Ma
Lei Wang
Jian Zhu
Feng Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.705669

3,665 views
3 citations

Systematic Review

Published on 29 Oct 2021

Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review

in Drugs Outcomes Research and Policies

Yan-Li Yang
Zi-Jian Xiang
Jing-Hua Yang
Wen-Jie Wang
Zhi-Chun Xu
Ruo-Lan Xiang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.697330

9,466 views
31 citations

Systematic Review

Published on 28 Oct 2021

Bleeding Outcomes After Dental Extraction in Patients Under Direct-Acting Oral Anticoagulants vs. Vitamin K Antagonists: A Systematic Review and Meta-Analysis

in Drugs Outcomes Research and Policies

Wenbing Hua
Zhengmei Huang
Zhuoli Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.702057

5,717 views
12 citations

Original Research

Published on 28 Oct 2021

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database

in Drugs Outcomes Research and Policies

Marion Allouchery
Cécile Tomowiak
Thomas Lombard
Marie-Christine Pérault-Pochat
Francesco Salvo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.769315

6,733 views
16 citations

Original Research

Published on 27 Oct 2021

Factors Associated With the Acceleration of Patient Enrollment in Clinical Studies: A Cross-Sectional Study

in Drugs Outcomes Research and Policies

Rieko Ueda
Yuji Nishizaki
Shuko Nojiri
Hiroshi Iwata
Katsumi Miyauchi
Kotone Matsuyama
Shoji Sanada
Tohru Minamino
Hiroyuki Daida

Frontiers in Pharmacology

doi 10.3389/fphar.2021.753067

4,458 views
3 citations

Systematic Review

Published on 25 Oct 2021

Pharmacist‐Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review

in Drugs Outcomes Research and Policies

Peipei Xu
Qiusha Yi
Cuitong Wang
Linan Zeng
Keith M. Olsen
Rongsheng Zhao
Mingyan Jiang
Ting Xu
Lingli Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.741724

4,954 views
10 citations

Original Research

Published on 22 Oct 2021

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)

in Drugs Outcomes Research and Policies

Alvaro Quincho-Lopez
Josmel Pacheco-Mendoza

Frontiers in Pharmacology

doi 10.3389/fphar.2021.702937

3,874 views
10 citations

Methods

Published on 22 Oct 2021

An Objective Approach to Identify Priority Rare Diseases for the Development of Solutions Reducing the Diagnostic Delay Based on French Data

in Drugs Outcomes Research and Policies

Pierre Etienne Chazal
Ségolène Aymé

Frontiers in Pharmacology

doi 10.3389/fphar.2021.734601

4,746 views
5 citations

Systematic Review

Published on 21 Oct 2021

Efficacy and Safety of Lipid-Lowering Drugs of Different Intensity on Clinical Outcomes: A Systematic Review and Network Meta-Analysis

in Drugs Outcomes Research and Policies

Wenrui Ma
Qinyuan Pan
Defeng Pan
Tongda Xu
Hong Zhu
Dongye Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.713007

7,865 views
17 citations

Systematic Review

Published on 20 Oct 2021

The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review

in Drugs Outcomes Research and Policies

Jiaxing Zhang
Yihong Xie
Joey Sum-wing Kwong
Long Ge
Rui He
Wenyi Zheng
Jing Han
Rui Zhang
Huaye Zhao
Yuru He

Frontiers in Pharmacology

doi 10.3389/fphar.2021.667027

4,789 views
4 citations

Original Research

Published on 20 Oct 2021

Status and Safety Signals of Cephalosporins in Children: A Spontaneous Reporting Database Study

in Drugs Outcomes Research and Policies

Yuanxuan Cai
Linhui Yang
Xiaofang Shangguan
Yuhang Zhao
Rui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.736618

5,528 views
6 citations

Navigation group

Articles

Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer in China

Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation

Drug-Repositioning Approaches Based on Medical and Life Science Databases

HIV Protease Inhibitors and Insulin Sensitivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Comparison of Primary and Secondary Prophylaxis Using PEGylated Recombinant Human Granulocyte–Stimulating Factor as a Cost-Effective Measure in Malignant Neoplasms: A Multicenter Retrospective Study

Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials

Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review

Bleeding Outcomes After Dental Extraction in Patients Under Direct-Acting Oral Anticoagulants vs. Vitamin K Antagonists: A Systematic Review and Meta-Analysis

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database

Factors Associated With the Acceleration of Patient Enrollment in Clinical Studies: A Cross-Sectional Study

Pharmacist‐Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)

An Objective Approach to Identify Priority Rare Diseases for the Development of Solutions Reducing the Diagnostic Delay Based on French Data

Efficacy and Safety of Lipid-Lowering Drugs of Different Intensity on Clinical Outcomes: A Systematic Review and Network Meta-Analysis

The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review

Status and Safety Signals of Cephalosporins in Children: A Spontaneous Reporting Database Study